Dates and Times
End Date: 3/13/2012
ObjectivesUpon completion of this educational activity, the participant should be able to: 1.) Describe current advances in the selection of treatment strategies for patients with stages II and III colorectal cancer. 2.)Describe the role of integrating biologics to cytotoxics in the treatment of stage IV colorectal cancer. 3.) Review the current screening guidelines for colorectal cancer screening 4.) Review the pathogenesis and genetics of colon carcinogenesis
PDF of Slides
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.